Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Researchers report in vivo data for ZP-GA-1

July 14, 2014

Researchers present promising preclinical data for HM-12525A

July 14, 2014

Givinostat shows activity in models of glioblastoma

July 11, 2014

Clinical results reported for TTP-399, a liver-selective GKA for type 2 diabetes

July 11, 2014

Kyoto Pharmaceutical's PTP-1B inhibitor, a promising candidate for diabetes and obesity

July 11, 2014

CNX-013-B2, a pan-PPAR activator for diabetes and obesity

July 11, 2014

Researchers present phase I results for LGD-6972

July 10, 2014

LAPS-CA-Exendin 4 designed for patients with type 2 diabetes

July 10, 2014

Phase III results for trelagliptin, an oral, once-weekly DPP IV inhibitor

July 10, 2014

Researchers present results for BP-C1 in patients with stage IV breast cancer

July 10, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.